David Nield (Guest Writer) is a freelance journalist who has been writing about science and technology for more than 10 years. His work can be seen on The Guardian, Gizmodo, TechRadar, Digital Trends and numerous other places. @davidnield

E.J. Mundell is a reporter for HealthDay.

I’m the editor of BioPharma Dive, an online trade publication serving execs and professionals in the biotech and pharmaceutical industries. Before making the leap into business journalism, I worked as a healthcare reporter for ThinkProgress. And before that, I was enjoying the quaint New Hampshire life at Dartmouth College, from where I graduated in 2012 with a double-major in Government and Religious Studies, focusing on American public policy and healthcare policy. I’ve been published in the Huffington Post, U.S. News and World Report, and Seeking Alpha, among others. In my spare time, I cook a mean Indian dish or two.

Seen in HealthDay, CBS News, CBS MoneyWatch, CBS Newspath, U.S. News & World Report, WebMD, Chicago Tribune, Barrington Courier-Review, Newsday, Phys.org, Vanity Fair and more

Laura McCaughey is a Sir Henry Wellcome Postdoctoral Research Fellow working at the ithree institute (infection, immunology and innovation) at the University of Technology, Sydney (UTS) and at the Biochemistry department at the University of Oxford. Research Areas include: Microbiology, Antibiotics, Bacteria, Antibiotic resistance, Drug discovery

Kevin Mathews is a contributor to Care2.com.

Peter Lusted is a journalist with the ABC News team in Melbourne covering news and sport. Peter has previously worked at ABC NewsRadio and 2UE.

Francisco López-Muñoz, MD, PhD, DLitt, received his PhD Degree in Medicine at Madrid Complutense University in 1993 (Doctorate Extraordinary Award), and another PhD Degree in Spanish Language and Literature at University of Alcalá in 2015. He is a specialist in Pharmaceutical Medicine, and postgraduate in Holocaust Studies by the International School for Holocaust Studies of Yad Vashem (Jerusalem, Israel). Currently he is Professor of Pharmacology, Director of International Doctorate School, Chairman of the Research Ethics Committee, and Assistant Director of Academic Staff at Camilo José Cela University, and Research Fellow at Hospital 12 de Octubre Research Institute (Madrid, Spain), and Portucalense Institute of Neuropsychology and Cognitive and Behavioral Neurosciences (INPP), Universidade Portucalense Infante Dom Henrique (Porto, Portugal). He has supervised 16 PhD theses, has participated in 33 research projects, and acts as evaluator of research projects and degrees for several European Agencies. Prof. López-Muñoz is editor/author of 25 books (such as the “History of Psychopharmacology”, in three volumes, edited by Editorial Medica Panamericana, Madrid, 2007, and NPP Books, Arlington, USA, 2014, “Neurobiology of Depression”, from the prestigious series Frontiers in Neuroscience, 2012, or “Melatonin, Neuroprotective Agents and Antidepressant Therapy”, edited by Springer International, 2016), and 215 chapters of books related to the psychopharmacology. He has published 370 articles (H-index = 30). Prof. López-Muñoz is member of several scientific societies (including Collegium Internationale Neuro-Psychopharmacologicum) and editorial boards, and has participated, as visiting Professor in different Spanish and international academic centres. Prof. López-Muñoz has various awards for his research career, and he is Academician of the Royal European Academy of Doctors and Correspondent Academician of the Royal Academy of Medicine and Surgery of Cádiz, and Royal Academy of History and Art of San Quirce, and Foreign Corresponding Academician of the National Academies of Medicine of Colombia, Venezuela, Paraguay and Dominican Republic. Research interest: Neuropsychopharmacology and Neurosciences: Biological bases of drug abuse and dual diagnosis, psychotropic drugs interactions, neurobiology of metal disorders, bibliometric techniques applied to mental health-related disciplines and neuropsychopharmacology, combination therapies with antidepressant drugs in resistant depression and with antipsychotics drugs in patients with refractory schizophrenia, and the history of the psychopharmacology and neurosciences.